nodes	percent_of_prediction	percent_of_DWPC	metapath
Amisulpride—Venous thromboembolism—Epirubicin—bone cancer	0.0324	0.0324	CcSEcCtD
Amisulpride—Venous thromboembolism—Doxorubicin—bone cancer	0.03	0.03	CcSEcCtD
Amisulpride—Sudden death—Methotrexate—bone cancer	0.0199	0.0199	CcSEcCtD
Amisulpride—Embolism venous—Epirubicin—bone cancer	0.0189	0.0189	CcSEcCtD
Amisulpride—Embolism venous—Doxorubicin—bone cancer	0.0175	0.0175	CcSEcCtD
Amisulpride—Deep vein thrombosis—Methotrexate—bone cancer	0.0167	0.0167	CcSEcCtD
Amisulpride—Hypokinesia—Epirubicin—bone cancer	0.0141	0.0141	CcSEcCtD
Amisulpride—Hypokinesia—Doxorubicin—bone cancer	0.0131	0.0131	CcSEcCtD
Amisulpride—Ventricular arrhythmia—Epirubicin—bone cancer	0.0129	0.0129	CcSEcCtD
Amisulpride—Orthostatic hypotension—Cisplatin—bone cancer	0.0123	0.0123	CcSEcCtD
Amisulpride—Ventricular arrhythmia—Doxorubicin—bone cancer	0.0119	0.0119	CcSEcCtD
Amisulpride—Sweating increased—Cisplatin—bone cancer	0.0113	0.0113	CcSEcCtD
Amisulpride—Breast pain—Epirubicin—bone cancer	0.0109	0.0109	CcSEcCtD
Amisulpride—Cardiovascular disorder—Epirubicin—bone cancer	0.0108	0.0108	CcSEcCtD
Amisulpride—Amenorrhoea—Epirubicin—bone cancer	0.0108	0.0108	CcSEcCtD
Amisulpride—Vaginal inflammation—Methotrexate—bone cancer	0.0102	0.0102	CcSEcCtD
Amisulpride—Pulmonary embolism—Methotrexate—bone cancer	0.0102	0.0102	CcSEcCtD
Amisulpride—Neuropathy peripheral—Cisplatin—bone cancer	0.0102	0.0102	CcSEcCtD
Amisulpride—Dyskinesia—Epirubicin—bone cancer	0.0101	0.0101	CcSEcCtD
Amisulpride—Breast pain—Doxorubicin—bone cancer	0.0101	0.0101	CcSEcCtD
Amisulpride—Amenorrhoea—Doxorubicin—bone cancer	0.01	0.01	CcSEcCtD
Amisulpride—Cardiovascular disorder—Doxorubicin—bone cancer	0.01	0.01	CcSEcCtD
Amisulpride—Vaginal infection—Methotrexate—bone cancer	0.00962	0.00962	CcSEcCtD
Amisulpride—Ventricular tachycardia—Epirubicin—bone cancer	0.00953	0.00953	CcSEcCtD
Amisulpride—Vaginal inflammation—Epirubicin—bone cancer	0.00953	0.00953	CcSEcCtD
Amisulpride—Pulmonary embolism—Epirubicin—bone cancer	0.00953	0.00953	CcSEcCtD
Amisulpride—Bradycardia—Cisplatin—bone cancer	0.00949	0.00949	CcSEcCtD
Amisulpride—Dyskinesia—Doxorubicin—bone cancer	0.00938	0.00938	CcSEcCtD
Amisulpride—Salivary hypersecretion—Epirubicin—bone cancer	0.00926	0.00926	CcSEcCtD
Amisulpride—Gynaecomastia—Methotrexate—bone cancer	0.00911	0.00911	CcSEcCtD
Amisulpride—Vaginal infection—Epirubicin—bone cancer	0.009	0.009	CcSEcCtD
Amisulpride—Vaginal inflammation—Doxorubicin—bone cancer	0.00882	0.00882	CcSEcCtD
Amisulpride—Pulmonary embolism—Doxorubicin—bone cancer	0.00882	0.00882	CcSEcCtD
Amisulpride—Ventricular tachycardia—Doxorubicin—bone cancer	0.00882	0.00882	CcSEcCtD
Amisulpride—Cardiac disorder—Cisplatin—bone cancer	0.00865	0.00865	CcSEcCtD
Amisulpride—Salivary hypersecretion—Doxorubicin—bone cancer	0.00857	0.00857	CcSEcCtD
Amisulpride—Immune system disorder—Cisplatin—bone cancer	0.00842	0.00842	CcSEcCtD
Amisulpride—Vaginal infection—Doxorubicin—bone cancer	0.00833	0.00833	CcSEcCtD
Amisulpride—Malnutrition—Cisplatin—bone cancer	0.00811	0.00811	CcSEcCtD
Amisulpride—Muscle spasms—Cisplatin—bone cancer	0.0078	0.0078	CcSEcCtD
Amisulpride—Tremor—Cisplatin—bone cancer	0.0076	0.0076	CcSEcCtD
Amisulpride—Leukopenia—Cisplatin—bone cancer	0.00726	0.00726	CcSEcCtD
Amisulpride—Convulsion—Cisplatin—bone cancer	0.00703	0.00703	CcSEcCtD
Amisulpride—Anxiety—Cisplatin—bone cancer	0.00688	0.00688	CcSEcCtD
Amisulpride—Unspecified disorder of skin and subcutaneous tissue—Cisplatin—bone cancer	0.00686	0.00686	CcSEcCtD
Amisulpride—Cardiac arrest—Epirubicin—bone cancer	0.00658	0.00658	CcSEcCtD
Amisulpride—Nervous system disorder—Cisplatin—bone cancer	0.00649	0.00649	CcSEcCtD
Amisulpride—Skin disorder—Cisplatin—bone cancer	0.00643	0.00643	CcSEcCtD
Amisulpride—Hyperhidrosis—Cisplatin—bone cancer	0.0064	0.0064	CcSEcCtD
Amisulpride—Orthostatic hypotension—Epirubicin—bone cancer	0.00632	0.00632	CcSEcCtD
Amisulpride—Hypotension—Cisplatin—bone cancer	0.00619	0.00619	CcSEcCtD
Amisulpride—Cardiac arrest—Doxorubicin—bone cancer	0.00609	0.00609	CcSEcCtD
Amisulpride—Neutropenia—Methotrexate—bone cancer	0.00598	0.00598	CcSEcCtD
Amisulpride—Erectile dysfunction—Methotrexate—bone cancer	0.00589	0.00589	CcSEcCtD
Amisulpride—Orthostatic hypotension—Doxorubicin—bone cancer	0.00585	0.00585	CcSEcCtD
Amisulpride—Gastrointestinal disorder—Cisplatin—bone cancer	0.00572	0.00572	CcSEcCtD
Amisulpride—Depression—Methotrexate—bone cancer	0.00568	0.00568	CcSEcCtD
Amisulpride—Neutropenia—Epirubicin—bone cancer	0.00559	0.00559	CcSEcCtD
Amisulpride—Weight increased—Epirubicin—bone cancer	0.00544	0.00544	CcSEcCtD
Amisulpride—Weight decreased—Epirubicin—bone cancer	0.00541	0.00541	CcSEcCtD
Amisulpride—Hyperglycaemia—Epirubicin—bone cancer	0.00539	0.00539	CcSEcCtD
Amisulpride—Agranulocytosis—Methotrexate—bone cancer	0.00532	0.00532	CcSEcCtD
Amisulpride—Neuropathy peripheral—Epirubicin—bone cancer	0.00523	0.00523	CcSEcCtD
Amisulpride—Neutropenia—Doxorubicin—bone cancer	0.00517	0.00517	CcSEcCtD
Amisulpride—Weight increased—Doxorubicin—bone cancer	0.00504	0.00504	CcSEcCtD
Amisulpride—Weight decreased—Doxorubicin—bone cancer	0.00501	0.00501	CcSEcCtD
Amisulpride—Hyperglycaemia—Doxorubicin—bone cancer	0.00499	0.00499	CcSEcCtD
Amisulpride—Agranulocytosis—Epirubicin—bone cancer	0.00498	0.00498	CcSEcCtD
Amisulpride—Hypersensitivity—Cisplatin—bone cancer	0.00488	0.00488	CcSEcCtD
Amisulpride—Bradycardia—Epirubicin—bone cancer	0.00487	0.00487	CcSEcCtD
Amisulpride—Neuropathy peripheral—Doxorubicin—bone cancer	0.00484	0.00484	CcSEcCtD
Amisulpride—Asthenia—Cisplatin—bone cancer	0.00475	0.00475	CcSEcCtD
Amisulpride—Cardiac disorder—Methotrexate—bone cancer	0.00475	0.00475	CcSEcCtD
Amisulpride—Angiopathy—Methotrexate—bone cancer	0.00464	0.00464	CcSEcCtD
Amisulpride—Immune system disorder—Methotrexate—bone cancer	0.00462	0.00462	CcSEcCtD
Amisulpride—Agranulocytosis—Doxorubicin—bone cancer	0.0046	0.0046	CcSEcCtD
Amisulpride—Diarrhoea—Cisplatin—bone cancer	0.00453	0.00453	CcSEcCtD
Amisulpride—Bradycardia—Doxorubicin—bone cancer	0.00451	0.00451	CcSEcCtD
Amisulpride—Mental disorder—Methotrexate—bone cancer	0.00448	0.00448	CcSEcCtD
Amisulpride—Malnutrition—Methotrexate—bone cancer	0.00445	0.00445	CcSEcCtD
Amisulpride—Cardiac disorder—Epirubicin—bone cancer	0.00444	0.00444	CcSEcCtD
Amisulpride—Angiopathy—Epirubicin—bone cancer	0.00434	0.00434	CcSEcCtD
Amisulpride—Immune system disorder—Epirubicin—bone cancer	0.00432	0.00432	CcSEcCtD
Amisulpride—Vomiting—Cisplatin—bone cancer	0.00421	0.00421	CcSEcCtD
Amisulpride—Mental disorder—Epirubicin—bone cancer	0.00419	0.00419	CcSEcCtD
Amisulpride—Malnutrition—Epirubicin—bone cancer	0.00417	0.00417	CcSEcCtD
Amisulpride—Cardiac disorder—Doxorubicin—bone cancer	0.00411	0.00411	CcSEcCtD
Amisulpride—Tension—Epirubicin—bone cancer	0.00409	0.00409	CcSEcCtD
Amisulpride—Nervousness—Epirubicin—bone cancer	0.00405	0.00405	CcSEcCtD
Amisulpride—Angiopathy—Doxorubicin—bone cancer	0.00402	0.00402	CcSEcCtD
Amisulpride—Muscle spasms—Epirubicin—bone cancer	0.00401	0.00401	CcSEcCtD
Amisulpride—Immune system disorder—Doxorubicin—bone cancer	0.004	0.004	CcSEcCtD
Amisulpride—Leukopenia—Methotrexate—bone cancer	0.00399	0.00399	CcSEcCtD
Amisulpride—Nausea—Cisplatin—bone cancer	0.00393	0.00393	CcSEcCtD
Amisulpride—Mental disorder—Doxorubicin—bone cancer	0.00388	0.00388	CcSEcCtD
Amisulpride—Convulsion—Methotrexate—bone cancer	0.00386	0.00386	CcSEcCtD
Amisulpride—Malnutrition—Doxorubicin—bone cancer	0.00386	0.00386	CcSEcCtD
Amisulpride—Agitation—Epirubicin—bone cancer	0.00383	0.00383	CcSEcCtD
Amisulpride—Tension—Doxorubicin—bone cancer	0.00378	0.00378	CcSEcCtD
Amisulpride—Unspecified disorder of skin and subcutaneous tissue—Methotrexate—bone cancer	0.00376	0.00376	CcSEcCtD
Amisulpride—Nervousness—Doxorubicin—bone cancer	0.00374	0.00374	CcSEcCtD
Amisulpride—Leukopenia—Epirubicin—bone cancer	0.00373	0.00373	CcSEcCtD
Amisulpride—Muscle spasms—Doxorubicin—bone cancer	0.00371	0.00371	CcSEcCtD
Amisulpride—Convulsion—Epirubicin—bone cancer	0.00361	0.00361	CcSEcCtD
Amisulpride—Hypertension—Epirubicin—bone cancer	0.0036	0.0036	CcSEcCtD
Amisulpride—Nervous system disorder—Methotrexate—bone cancer	0.00356	0.00356	CcSEcCtD
Amisulpride—Agitation—Doxorubicin—bone cancer	0.00354	0.00354	CcSEcCtD
Amisulpride—Anxiety—Epirubicin—bone cancer	0.00354	0.00354	CcSEcCtD
Amisulpride—Skin disorder—Methotrexate—bone cancer	0.00353	0.00353	CcSEcCtD
Amisulpride—Unspecified disorder of skin and subcutaneous tissue—Epirubicin—bone cancer	0.00352	0.00352	CcSEcCtD
Amisulpride—Hyperhidrosis—Methotrexate—bone cancer	0.00351	0.00351	CcSEcCtD
Amisulpride—Dry mouth—Epirubicin—bone cancer	0.00347	0.00347	CcSEcCtD
Amisulpride—Leukopenia—Doxorubicin—bone cancer	0.00345	0.00345	CcSEcCtD
Amisulpride—Hypotension—Methotrexate—bone cancer	0.0034	0.0034	CcSEcCtD
Amisulpride—Convulsion—Doxorubicin—bone cancer	0.00334	0.00334	CcSEcCtD
Amisulpride—Nervous system disorder—Epirubicin—bone cancer	0.00334	0.00334	CcSEcCtD
Amisulpride—Hypertension—Doxorubicin—bone cancer	0.00333	0.00333	CcSEcCtD
Amisulpride—Skin disorder—Epirubicin—bone cancer	0.0033	0.0033	CcSEcCtD
Amisulpride—Hyperhidrosis—Epirubicin—bone cancer	0.00329	0.00329	CcSEcCtD
Amisulpride—Insomnia—Methotrexate—bone cancer	0.00329	0.00329	CcSEcCtD
Amisulpride—Anxiety—Doxorubicin—bone cancer	0.00327	0.00327	CcSEcCtD
Amisulpride—Unspecified disorder of skin and subcutaneous tissue—Doxorubicin—bone cancer	0.00326	0.00326	CcSEcCtD
Amisulpride—Somnolence—Methotrexate—bone cancer	0.00323	0.00323	CcSEcCtD
Amisulpride—Dry mouth—Doxorubicin—bone cancer	0.00321	0.00321	CcSEcCtD
Amisulpride—Dyspepsia—Methotrexate—bone cancer	0.0032	0.0032	CcSEcCtD
Amisulpride—Hypotension—Epirubicin—bone cancer	0.00318	0.00318	CcSEcCtD
Amisulpride—Gastrointestinal disorder—Methotrexate—bone cancer	0.00314	0.00314	CcSEcCtD
Amisulpride—Fatigue—Methotrexate—bone cancer	0.00313	0.00313	CcSEcCtD
Amisulpride—Nervous system disorder—Doxorubicin—bone cancer	0.00309	0.00309	CcSEcCtD
Amisulpride—Insomnia—Epirubicin—bone cancer	0.00308	0.00308	CcSEcCtD
Amisulpride—Skin disorder—Doxorubicin—bone cancer	0.00306	0.00306	CcSEcCtD
Amisulpride—Hyperhidrosis—Doxorubicin—bone cancer	0.00304	0.00304	CcSEcCtD
Amisulpride—Somnolence—Epirubicin—bone cancer	0.00302	0.00302	CcSEcCtD
Amisulpride—Dyspepsia—Epirubicin—bone cancer	0.00299	0.00299	CcSEcCtD
Amisulpride—Gastrointestinal pain—Methotrexate—bone cancer	0.00297	0.00297	CcSEcCtD
Amisulpride—Hypotension—Doxorubicin—bone cancer	0.00294	0.00294	CcSEcCtD
Amisulpride—Gastrointestinal disorder—Epirubicin—bone cancer	0.00294	0.00294	CcSEcCtD
Amisulpride—Fatigue—Epirubicin—bone cancer	0.00293	0.00293	CcSEcCtD
Amisulpride—Constipation—Epirubicin—bone cancer	0.00291	0.00291	CcSEcCtD
Amisulpride—Urticaria—Methotrexate—bone cancer	0.00289	0.00289	CcSEcCtD
Amisulpride—Abdominal pain—Methotrexate—bone cancer	0.00287	0.00287	CcSEcCtD
Amisulpride—Insomnia—Doxorubicin—bone cancer	0.00285	0.00285	CcSEcCtD
Amisulpride—Somnolence—Doxorubicin—bone cancer	0.0028	0.0028	CcSEcCtD
Amisulpride—Gastrointestinal pain—Epirubicin—bone cancer	0.00278	0.00278	CcSEcCtD
Amisulpride—Dyspepsia—Doxorubicin—bone cancer	0.00277	0.00277	CcSEcCtD
Amisulpride—Gastrointestinal disorder—Doxorubicin—bone cancer	0.00272	0.00272	CcSEcCtD
Amisulpride—Fatigue—Doxorubicin—bone cancer	0.00271	0.00271	CcSEcCtD
Amisulpride—Urticaria—Epirubicin—bone cancer	0.0027	0.0027	CcSEcCtD
Amisulpride—Constipation—Doxorubicin—bone cancer	0.00269	0.00269	CcSEcCtD
Amisulpride—Abdominal pain—Epirubicin—bone cancer	0.00269	0.00269	CcSEcCtD
Amisulpride—Hypersensitivity—Methotrexate—bone cancer	0.00268	0.00268	CcSEcCtD
Amisulpride—Asthenia—Methotrexate—bone cancer	0.00261	0.00261	CcSEcCtD
Amisulpride—Gastrointestinal pain—Doxorubicin—bone cancer	0.00257	0.00257	CcSEcCtD
Amisulpride—Pruritus—Methotrexate—bone cancer	0.00257	0.00257	CcSEcCtD
Amisulpride—Hypersensitivity—Epirubicin—bone cancer	0.00251	0.00251	CcSEcCtD
Amisulpride—Urticaria—Doxorubicin—bone cancer	0.0025	0.0025	CcSEcCtD
Amisulpride—Abdominal pain—Doxorubicin—bone cancer	0.00249	0.00249	CcSEcCtD
Amisulpride—Diarrhoea—Methotrexate—bone cancer	0.00249	0.00249	CcSEcCtD
Amisulpride—Asthenia—Epirubicin—bone cancer	0.00244	0.00244	CcSEcCtD
Amisulpride—Pruritus—Epirubicin—bone cancer	0.00241	0.00241	CcSEcCtD
Amisulpride—Dizziness—Methotrexate—bone cancer	0.0024	0.0024	CcSEcCtD
Amisulpride—Diarrhoea—Epirubicin—bone cancer	0.00233	0.00233	CcSEcCtD
Amisulpride—Hypersensitivity—Doxorubicin—bone cancer	0.00232	0.00232	CcSEcCtD
Amisulpride—Vomiting—Methotrexate—bone cancer	0.00231	0.00231	CcSEcCtD
Amisulpride—Headache—Methotrexate—bone cancer	0.00228	0.00228	CcSEcCtD
Amisulpride—Asthenia—Doxorubicin—bone cancer	0.00226	0.00226	CcSEcCtD
Amisulpride—Dizziness—Epirubicin—bone cancer	0.00225	0.00225	CcSEcCtD
Amisulpride—Pruritus—Doxorubicin—bone cancer	0.00223	0.00223	CcSEcCtD
Amisulpride—Vomiting—Epirubicin—bone cancer	0.00216	0.00216	CcSEcCtD
Amisulpride—Nausea—Methotrexate—bone cancer	0.00216	0.00216	CcSEcCtD
Amisulpride—Diarrhoea—Doxorubicin—bone cancer	0.00215	0.00215	CcSEcCtD
Amisulpride—Headache—Epirubicin—bone cancer	0.00213	0.00213	CcSEcCtD
Amisulpride—Dizziness—Doxorubicin—bone cancer	0.00208	0.00208	CcSEcCtD
Amisulpride—Nausea—Epirubicin—bone cancer	0.00202	0.00202	CcSEcCtD
Amisulpride—Vomiting—Doxorubicin—bone cancer	0.002	0.002	CcSEcCtD
Amisulpride—Headache—Doxorubicin—bone cancer	0.00197	0.00197	CcSEcCtD
Amisulpride—Nausea—Doxorubicin—bone cancer	0.00187	0.00187	CcSEcCtD
